Starting clozapine in patients with schizophrenia during the ongoing pandemic.

Grover, Sandeep; Naskar, Chandrima; Sahoo, Swapnajeet; Mehra, Aseem; Chakrabarti, Subho

Grover, Sandeep; Naskar, Chandrima; Sahoo, Swapnajeet; Mehra, Aseem; Chakrabarti, Subho.

Grover S; Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India. Electronic address: drsandeepg2002@yahoo.com.
Naskar C; Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Sahoo S; Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Mehra A; Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Chakrabarti S; Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.

Schizophr Res ; 243: 440-442, 2022 05.

Article in English | MEDLINE | ID: covidwho-1321467

Subject(s)

Antipsychotic Agents; Clozapine; Schizophrenia; Antipsychotic Agents/therapeutic use; Clozapine/therapeutic use; Humans; Longitudinal Studies; Pandemics; Schizophrenia/drug therapy; Schizophrenia/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Clozapine Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Schizophr Res Journal subject: Psychiatry Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google